2026 NPPES data Hematology & Oncology Physician NPI 1144504408 M.D
Verify on CMS →

NWABUNDO ANUSIM, M.D

Hematology & Oncology Physician in AUSTIN, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
169
Medicare Part D claims · 55 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
82%
generic claims · 18% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
73.1096/100
▼ 10 pts below national avg 83.1 · [object Object]
Industry payments
$212.98
12 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: NWABUNDO ANUSIM, M.D is a Hematology & Oncology Physician ([object Object]) practicing in AUSTIN, Texas with a Medicare Part D prescribing footprint of 169 claims across 55 beneficiaries — 18% brand-name prescribing . Their CMS MIPS Final Score of 73.1096/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $212.98 across 12 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: NWABUNDO ANUSIM, M.D reported a CMS MIPS final score of 73.1096 out of 100, below the 83.1 national average, and filed 169 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

NWABUNDO ANUSIM, M.D practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 2 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

NWABUNDO ANUSIM, M.D at a glance

Below national average

NPI registry status

Active

Issued 10/05/2011

NPI 1144504408

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

169 80% vs specialty avg

2023 prescription claims

Specialty avg: 847

MIPS final score

73.1096/100 9.990399999999994% pts

Mid-tier band

vs 83.1 national avg

Specialty distribution in Texas

How Hematology & Oncology Physician compares to other specialties among Texas providers

Texas providers

Hematology & Oncology Physician share within Texas

1. Hematology & Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Hematology & Oncology Physician share within Texas

Medicare quality performance — MIPS

NWABUNDO ANUSIM, M.D's 2023 MIPS final score plotted against the Hematology & Oncology Physician national average

Below national average
MIPS Final Score
73.1096/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Hematology & Oncology Physician) — 73.1096/100 vs national avg 83.1

0%100%National avg83%73.1%
MIPS final score (Hematology & Oncology Physician) — 73.1096/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

NWABUNDO ANUSIM, M.D is a Hematology & Oncology Physician provider practicing in AUSTIN, Texas, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D. NPI: 1144504408. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

NWABUNDO ANUSIM, M.D appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding M.D credentials at 1601 TRINITY ST, AUSTIN, TX, 78712, with a listed phone of (574) 335-5000. NPI 1144504408 was issued on 10/05/2011. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ANUSIM most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 169 prescription claims written by this provider, covering 55 Medicare beneficiaries and totaling roughly $415K in drug spend, split 18% brand-name and 82% generic by claim count, with an opioid prescribing rate of 30.8%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 73.1096/100 for the 2023 performance year (Quality 63.2667, Cost 47.0987), compared with the national average of 83.1.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1601 TRINITY ST
AUSTIN, TX 78712

Provider Details

NPI 1144504408
Specialty Hematology & Oncology Physician
Credentials M.D
Gender Female
NPI Issued 10/05/2011

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

73.1096
Final Score
Avg: 83.1
63.2667
Quality
47.0987
Cost
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where NWABUNDO ANUSIM, M.D bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

HENDRICK PROVIDER NETWORK
BROWNWOOD, TX
SHANNON CLINIC
SAN ANGELO, TX

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for NWABUNDO ANUSIM, M.D. Source: openpaymentsdata.cms.gov.

Total received

$213

Largest payer

E.R. Squibb & Sons, L.L.C.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Texas TMB 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to NWABUNDO ANUSIM, M.D. To verify NWABUNDO ANUSIM, M.D's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

NWABUNDO ANUSIM, M.D — brand share 18.0%
Specialty average (est.)

18% brand-name claims vs 82% generic, on 169 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

169
Total Claims
$415K
Total Drug Cost
55
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
190
Total Day Supply
4,373
Brand vs Generic
18% brand / 82% generic
Brand Drug Cost
$407K
Generic Drug Cost
$8K
Opioid Claims
52 (30.8% rate)

Patient Demographics

Average Patient Age
70.2 years
Avg HCC Risk Score
2.23
Gender Split
62% female / 38% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Hydrocodone-Acetaminophen
Hydrocodone/Acetaminophen
33
Anastrozole
15
Xtandi
Enzalutamide
13
Ondansetron Hcl
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How NWABUNDO ANUSIM, M.D fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

NWABUNDO ANUSIM, M.D's 169 claims are below the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as ANUSIM.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is NWABUNDO ANUSIM, M.D's specialty?
NWABUNDO ANUSIM, M.D specializes in Hematology & Oncology Physician and practices in AUSTIN, Texas. Credentials: M.D.
How much does NWABUNDO ANUSIM, M.D prescribe under Medicare Part D?
In 2023, NWABUNDO ANUSIM, M.D wrote 169 Medicare Part D claims totaling $415K in drug costs for 55 beneficiaries.
What is NWABUNDO ANUSIM, M.D's Medicare quality score?
NWABUNDO ANUSIM, M.D has a CMS MIPS Final Score of 73.1096/100 (Quality: 63.2667, Cost: 47.0987). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is NWABUNDO ANUSIM, M.D located?
NWABUNDO ANUSIM, M.D is located at 1601 TRINITY ST, AUSTIN, TX, 78712. Phone: (574) 335-5000.
What is NWABUNDO ANUSIM, M.D's NPI number?
NWABUNDO ANUSIM, M.D's National Provider Identifier (NPI) is 1144504408, issued on 10/05/2011.
Does NWABUNDO ANUSIM, M.D prescribe more brand-name or generic drugs?
NWABUNDO ANUSIM, M.D's prescribing is 18% brand-name and 82% generic drugs by claim count, with $407K in brand drug costs.
Does NWABUNDO ANUSIM, M.D prescribe opioids?
Yes, NWABUNDO ANUSIM, M.D had 52 opioid claims in 2023 with an opioid prescribing rate of 30.8%.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does NWABUNDO ANUSIM, M.D prescribe most often?
Based on 2023 Medicare Part D data, NWABUNDO ANUSIM, M.D's most frequently prescribed drugs include Hydrocodone-Acetaminophen, Anastrozole, Xtandi. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does NWABUNDO ANUSIM, M.D accept Medicare?
NWABUNDO ANUSIM, M.D appears in CMS Medicare data with 169 Part D claims and 55 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify NWABUNDO ANUSIM, M.D's credentials?
NWABUNDO ANUSIM, M.D's NPI is 1144504408 with credentials M.D. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology